Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Current Deferred Revenue (2018 - 2025)

Solesence's Current Deferred Revenue history spans 9 years, with the latest figure at $930000.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 83.31% year-over-year to $930000.0; the TTM value through Dec 2025 reached $930000.0, down 83.31%, while the annual FY2025 figure was $930000.0, 83.31% down from the prior year.
  • Current Deferred Revenue reached $930000.0 in Q4 2025 per SLSN's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $6.2 million in Q3 2024 to a low of $388000.0 in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $2.1 million, with a median of $1.9 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 227.38% in 2023, then crashed 83.31% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $783000.0 in 2021, then skyrocketed by 176.76% to $2.2 million in 2022, then rose by 8.58% to $2.4 million in 2023, then soared by 136.76% to $5.6 million in 2024, then plummeted by 83.31% to $930000.0 in 2025.
  • Per Business Quant, the three most recent readings for SLSN's Current Deferred Revenue are $930000.0 (Q4 2025), $1.2 million (Q3 2025), and $2.2 million (Q2 2025).